secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001356576-25-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus approves executive salary increases and equity awards for 2025
-----------------------------------------------------------------------

- CEO Jack Khattar base salary raised to $1,036,000; 2024 bonus $826,254; awarded 331,660 options and 198,996 PSUs.
- CFO Timothy Dec base salary raised to $504,900; 2024 bonus $229,160; awarded 40,000 options, 4,500 RSUs, 5,000 PSUs.
- Three other execs (Bhatt, Rubin, Mottola) got salary increases, 2024 bonuses, and similar equity grants.
- All 2025 bonus targets unchanged from 2024; salary increases effective Jan 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000011/0001356576-25-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000011/supn-20250224.htm
  HTML page:      https://secwatch.observer/filing/0001356576-25-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer